It is paramount to understand the epidemiology of chronic Hepatitis B to inform national policies on vaccination and screening/testing as well as costeffectiveness studies. However, information on the national (Scottish) prevalence of chronic Hepatitis B by ethnic group is lacking. To estimate the number of people with chronic Hepatitis B in Scotland in 2009 by ethnicity, gender and age, the test data from virology laboratories in the four largest cities in Scotland were combined with estimates of the ethnic distribution of the Scottish population. Ethnicity in both the test data and the Scottish population was derived using a name-based ethnicity classification software (Onomap). For 2009, we estimated 8720 (95% confidence interval: 7490 to 10230) people aged 15 and older were living with chronic hepatitis B infection in Scotland. This corresponds to 0.2% (CI: 0.17% to 0.24%) of the Scottish population aged 15 and older. Although East and South Asians make up a small proportion of the Scottish population, they make up 44% of the infected population. In addition, 75% of those infected are aged 15-44 and almost 60% are male. This study quantifies for the first time on a national level the burden of chronic hepatitis B infection by ethnicity, gender and age. It confirms the importance of promoting and targeting ethnic minority groups for hepatitis B testing.
INTRODUCTION
Worldwide, it has been estimated that about 2 billion people have been infected with hepatitis B virus (HBV). 240 million have chronic HBV infection (CHB) and 600000 die each year either from CHB-associated liver cirrhosis or hepatocellular carcinoma [1] . A UK prevalence of 0.3% for CHB has been reported by the Department of Health [2] . This estimate relates to data from antenatal screening tests in the West Midlands between 1983 and 1985 [3] . More recently, a higher prevalence of 0.45% has been predicted for England and Wales as a result of modeling data on notifications of acute HBV [4] . Generally, higher prevalences of CHB have been found amongst men and older people [5] and in members of certain ethnic minority groups, especially South Asians and East Asians [6] , [7] .
In the UK, universal infant or adolescent immunisation is not considered cost-effective [8] . Instead, the joint Committee on Vaccination and Immunization has recommended that HBV immunisation should be targeted at individuals at high risk of HBV exposure and at people at increased risk of complications should they acquire HBV [9] .
Early diagnosis and treatment of HBV is cost-effective [10] , but identification of individuals, who are often asymptomatic, is difficult. In The Netherlands and Canada, both countries with a low HBV prevalence [11] , screening first generation migrants and early treatment of those with CHB has been shown to be cost-effective [12] , [13] . HBV testing has been part of the UK antenatal screening programme since 1998 [14] . Recent guidance from the National Institute for Health and Clinical Excellence (NICE) recommends testing people at increased risk of HBV infection. Those at higher risk are particularly migrants from medium-or high-prevalence countries, people who inject or have injected drugs and men who have sex with men [15] .
Until now, most studies on HBV prevalence have focussed on the tested population without comparisons made to the general population. In this study, we have developed an approach based on a combination of HBV laboratory test data with estimates of the Scottish population as a means to estimate, by major ethnic groups, the number of people living with CHB in Scotland. This approach is of paramount importance to guide national policy and screening strategies.
Nevertheless, despite it not being a resource intensive approach, it has not hitherto been implemented.
METHODS
Laboratory HBV test data were used to determine the prevalence of CHB by ethnic background in (i) women undergoing an antenatal screen, and (ii) women and men tested in other primary and secondary care settings. The former gives information on the prevalence of CHB in females of childbearing age, while the latter gives information on differences in the prevalence of CHB by age and gender. To generate an estimate of the prevalence of CHB infection among adults living in Scotland, estimates of CHB prevalence by age, gender and ethnicity were then combined with estimates of the general Scottish population.
Laboratory data
The virology laboratories in the four largest cities in Scotland (Aberdeen, Dundee, Hepatitis B surface antigen (HBsAg)-positive tests and HBsAg-negative tests were used to define infected and uninfected individuals, respectively. Indeterminate, weak positive or inconclusive results were excluded. In order to ensure that HBV infection included in the study was CHB, an assessment of HBV positive individuals was performed. An HBsAg positive individual was excluded if there was (1) a negative test within 180 days before the first positive HBsAgtest or (2) a positive test for IgM antibodies to the hepatitis B core antigen at the time of the first positive HBsAg-test.
Ethnicity was assigned using a name-based 'ethnicity' classification methodology (Onomap). The Onomap software classifies ethnicity based on a comparison of forename and surname against a database of names sourced from public name registries from over 26 countries. In order to correct for misclassification in the assignment of ethnicity, predictive values from a recent validation study of Onomap have been used [16] . This study, set in the Scottish population and involving large datasets of birth registrations and the pupil census, concluded that Onomap was an effective methodology for categorizing populations into a variety of ethnic groups. When comparing predictions from Onomap to birth registrations, the study found predictive values to determine British ethnicity of 94.6% (positive predictive value, PPV; the proportion of people determined by Onomap to belong to a certain ethnic group which truly belong to that ethnic group) and 74.4% (negative predictive value, NPV;
the proportion of people determined by Onomap to not belong to a certain ethnic group which truly don't belong to that ethnic group), 154927 HBsAg tests on the laboratory database were recognized as antenatal tests. Although it was not possible to identify all antenatal tests in the database, it was assumed that misclassification in the database was non-differential.
Prevalence was stratified according to age (15- HBV prevalence in women older than 44 years and men older than 14 years, by ethnicity CHB prevalence in women older than 44 years and men older than 14 years was estimated using as a starting point the estimated prevalence generated for women aged 15-44 years (as described above). Estimates were then adjusted according to relative differences in prevalence for the former groups, as determined from examination of data on all men and women tested for HBsAg in primary and secondary health care settings (excluding antenatal screens). Similarly, no significant interaction between age and gender was found and the interaction term was therefore not included in regression models.
For each ethnic group, the estimated prevalence of HBsAg positivity in women older than 44 years was calculated by multiplying the prevalence in women aged 15-29 years (generated from the antenatal test data) with the relative risk of testing HBsAg-positive among women older than 44 years compared to those aged 15-29 years (generated from primary and secondary health care test data). The prevalence in men was similarly estimated, applying the relative risk for men compared to women. For example, to estimate the prevalence in British men older than 44 years, the prevalence in British women, aged 15-29 years (0.16%, Table 1 ) was multiplied with the adjusted relative risk of British men and women older than 44 year compared to British men and women aged 15-29 years (RR 0.3, Table 2 ). The resulting product (0.05%) was then multiplied with the adjusted relative risk of British men compared to British women (RR 1.69, Table 2 ) resulting in an estimated prevalence of 0.08% (Table 4 ).
In estimating the ethnic-specific CHB prevalences in older women and men, it was assumed that the relative risks, as calculated from tests conducted in primary and secondary health care settings, were representative of differences in the general population. with mean and the SE as published by [16] . In generalizing results to the Scottish population, it was assumed that the ethnicity, gender and age-specific CHB prevalence estimates for the four largest Scottish NHS boards was representative of the Scottish population. 
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Through the approach of applying Onomap to the CHI database it was estimated that 1.5% and 0.7% of the Scottish population aged 15 years or older in 2009 were of South Asian and East Asian ethnicity, respectively (Table 3) . For South Asians, the estimate was higher than that reported from the 2001 Sottish Census (1.0%) and from [20] for the year 2010 (1.1%). For East Asians, it was higher than that reported from the 2001 census (0.3%), but comparable to the 
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By applying the CHB prevalence estimates ( 
DISCUSSION
This is the first time a CHB prevalence of 0.2% for all Scotland has been predicted based on a combination of laboratory data and population demographics. This prevalence was slightly lower than the generally accepted figure of 0.3% for the UK population [2] and less than half of the most recent published prevalence of 0.45% in England and Wales [4] . These differences in predictions could be explained by differences in the ethnic composition of the Scottish population (98% 'White' in the 2001 census) compared to the English population (91% 'White' in the 2001 census). Additionally, these differences may be explained by different assumptions made about the prevalence of CHB in men compared to women. In the study with 0.3% CHB [2] it was assumed that compared to women, men had a two-fold higher risk, while our study indicated that gender differences in CHB prevalence were modified by ethnicity. Asian males compared to females of the same ethnicity were unexpected. Additional information on exposure risks through enhanced surveillance with local NHS Boards -responsible for following up new cases and contact tracing -is needed to explain these results.
Given the high prevalence of CHB in ethnic minority groups, estimates of the ethnic composition of the general population are crucial but rarely available.
In this study we present a novel approach to estimate the proportion of East Asians and South Asians in the Scottish population using a name-based ethnicity classification software applied to data on all people registered with a GP in Scotland (CHI database). We aim to extend this to other ethnic groups (in Efforts to target the Chinese population and other ethnic minority groups for HBV testing and immunisation are already under way in Scotland (Andrew Bathgate, personal communication), the rest of the UK [21] and in other European Countries [22] , [23] . Without such initiatives to diagnose CHB infected individuals (particularly men, as they are not covered through antenatal screening) cases go undiagnosed until symptoms develop.
Our study had several limitations. Whilst we give 95% confidence intervals for our prevalence estimates, we could only take account of the statistical uncertainty in the estimated prevalence of i) CHB in the antenatal population, ii) the relative risk of testing HBsAg-positive among women older than 44 years compared to those aged 15-29 years and men compared to women; and iii) the predictive values for Onomap classification.
In order to estimate the prevalence of CHB in men and in women older than 44 years, it was assumed that the relative risks, as calculated from HBV tests conducted in primary and secondary health care settings, were representative of differences in the general population. This assumption is supported by a comparison of CHB prevalences between women aged 15 to 29 years and those aged 30 to 44 years in antenatal tests and in primary and secondary care. In antenatal tests of British and Other women, those aged 15 to 29 had a 1.6 times higher prevalence compared to those aged 30 to 44 years. In tests taken in primary and secondary care the rate between the two age groups was a similar 1.3. In antenatal tests of South Asian women, those aged 15 to 29 had a 0.5 times lower prevalence compared to those aged 30 to 44 years. In tests taken in primary and secondary care the rate between the two age groups was a similar 0.8. However, it is possible that the estimated relative risks are confounded by different indications for testing in the different age and gender strata. Reasons for HBV testing are not routinely recorded with the laboratory surveillance data and could therefore not be included in the analysis.
We relied on estimates for the PPV and NPV from Lakha et al. [16] to adjust for misclassification of Onomap in generating estimates of Scotland's population by ethnicity in 2009. The distribution of the Scottish population derived through this process was similar to that reported by Wohland et al. [20] . Slightly higher estimates of the proportion of South Asian males in the latter study would have little effect on the predicted prevalence of CHB in Scotland, a reduction by 0.008%.
In our analysis, people from low HBV prevalence countries (e.g. the UK and Northern Europe) were grouped together with people from medium and high prevalence countries (e.g. Eastern and Southern Europe, Africa) due to the sub-optimal performance of Onomap to accurately classify names relating to the latter ethnic groups [16] . The prevalence observed from antenatal tests in the British and Other stratum (0.13%) was therefore higher than in British women alone (0.06%) ; the observed higher prevalence in those aged 15-29 compared to 30-44 years in the British and Other ethnicity could be due to a higher proportion of the younger group originating from medium and high prevalence countries.. Further work is therefore needed to accurately predict the numbers of people with CHB within ethnic minority groups, other than East and South Asians.
Name-based 'ethnicity' classification is routinely used by Public
Health England to assign ethnicity to laboratory test data [24] . In the absence of information on ethnic background of people tested for CHB in various settings, use of full names was here the only way to attribute ethnicity and calculate reliable estimates of national prevalence. Consent to generate ethnicity data from the thousands of individuals undergoing a HBV test was not retrospectively sought.
Permission to use personal information was however granted by HPS' Clinical Governance Committee, as the public health gain of this exercise far outweighed the negligible risk to the individual. Namebased 'ethnicity' classification was not available for tests conducted in sexual health clinics or occupational health in Scotland, because these usually do not share personal identifiers without explicit permission.
In conclusion, this study has estimated that in Scotland in 2009 approximately 8700 people over the age of 14 (0.2% of this population) were infected with CHB. Slightly less than half of the infected population belongs to ethnic minority groups. There is a need to identify the undiagnosed population and thereby to prevent disease progression into liver cirrhosis and liver cancer and to prevent spread of disease into the non-infected population. To this end, novel strategies should be developed to promote and offer testing to people at increased risk of CHB. Indeed, the Scottish Government's Sexual Health and Blood-borne Virus Framework aims to better targeted testing, early diagnosis and effective treatment and care of blood borne virus infections [25] . Our study has also demonstrated that even without access to population sizes from census statistics, the size of the infected population in a nation can be estimated. 
Supplementary Material
Calculation of the size of the Scottish population by ethnicity, sex and age group (Table 3 ) -adjustments for the predictive values of name classification using Onomap and for the predicted size of the population. The positive predictive value of a test can be calculated as
where a is the number of true positives and a + b is the number of test positives.
Similarly, the negative predictive value can be calculated as
where c is the number of true negatives and c+d is the number of test negatives.
To estimate the adjusted total number of people in the CHI database that belong to ethnic group i, we calculated
where P i denotes the adjusted number, P P V * (a + b) denotes the number of people that were rightly classified by Onomap to belong to ethnic group i and (1 − N P V ) * (c + d) denotes the number of people that were wrongly classified by the software as not belonging to ethnic group i.
Once P i had been calculated, the size of the different age and sex strata in the extract from CHI could be estimated assuming that both age and sex had been recorded in the CHI database without misclassification and that misclassification by Onomap was not modified by age group or sex.
As the number of people in the CHI database by age and sex does not accurately estimate the size of the Scottish population, estimates for the latter were extracted from GRO. People in the different age and sex strata in the Scottish population were then assigned an ethnic group based on the (Onomapadjusted) distribution of ethnic groups in the CHI extract.
